3-Cyano-5-hydroxyphenyl 4-benzhydrylpiperidine-1-carboxylate

ID: ALA4540953

PubChem CID: 118679375

Max Phase: Preclinical

Molecular Formula: C26H24N2O3

Molecular Weight: 412.49

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  N#Cc1cc(O)cc(OC(=O)N2CCC(C(c3ccccc3)c3ccccc3)CC2)c1

Standard InChI:  InChI=1S/C26H24N2O3/c27-18-19-15-23(29)17-24(16-19)31-26(30)28-13-11-22(12-14-28)25(20-7-3-1-4-8-20)21-9-5-2-6-10-21/h1-10,15-17,22,25,29H,11-14H2

Standard InChI Key:  NFAYQCDYTAIPCO-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   37.8253  -27.0990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5322  -27.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2413  -27.1036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2443  -26.2819    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.5319  -25.8723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8167  -26.2802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9529  -25.8749    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6638  -26.2851    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.9547  -25.0536    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.3765  -25.8780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0862  -26.2919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7984  -25.8855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.8007  -25.0633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0848  -24.6492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3754  -25.0620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1146  -27.5136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4017  -27.1027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1167  -28.3349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4018  -26.2836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6897  -25.8769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9780  -26.2874    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9828  -27.1129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6954  -27.5200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4046  -28.7423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4064  -29.5628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1198  -29.9745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8329  -29.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8277  -28.7364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.5061  -26.2924    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.2169  -26.7070    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.0837  -23.8279    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  7  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  1 16  1  0
 16 17  1  0
 16 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 17  1  0
 18 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 18  1  0
 29 30  3  0
 12 29  1  0
 14 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4540953

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 412.49

Molecular Weight (Monoisotopic): 412.1787

AlogP: 5.31

#Rotatable Bonds: 4

Polar Surface Area: 73.56

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: 1

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 7.91

CX Basic pKa: ┄

CX LogP: 5.38

CX LogD: 5.27

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.63

Np Likeness Score: -0.45

References

1. Alapafuja SO, Malamas MS, Shukla V, Zvonok A, Miller S, Daily L, Rajarshi G, Miyabe CY, Chandrashekhar H, Wood J, Tyukhtenko S, Straiker A, Makriyannis A..  (2019)  Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.,  27  (1): [PMID:30446439] [10.1016/j.bmc.2018.11.003]

Source

Source(1):

• Scientific Literature